Fermentanomics: Monitoring Mammalian Cell Cultures with NMR Spectroscopy

被引:63
|
作者
Bradley, Scott A. [1 ]
Ouyang, Anli [2 ]
Purdie, Jennifer [2 ]
Smitka, Tim A. [1 ]
Wang, Tongtong [2 ]
Kaerner, Andreas [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Analyt Sci Res & Dev, Indianapolis, IN 46285 USA
[2] Eli Lilly & Co, Lilly Corp Ctr, Bioproc Res & Dev, Indianapolis, IN 46285 USA
关键词
D O I
10.1021/ja101962c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
As the number of therapeutic proteins produced by mammalian cell cultures in the pharmaceutical industry continues to increase, the need to improve productivity and ensure consistent product quality during process development activities becomes more significant. Rational medium design is known to improve cell culture performance, but an understanding of nutrient consumption and metabolite accumulation within the medium is required. To this end, we have developed a technique for using 1D H-1 NMR to quantitate nonprotein feed components and metabolites in mammalian cell cultures. We refer to the methodology as "Fermentanomics" to differentiate it from standard metabolomics. The method was found to generate spectra with excellent water suppression, signal-to-noise, and resolution. More importantly, nutrient consumption and metabolite accumulation was readily observed. In total, 50 media components have been identified and quantitated. The application of Fermentanomics to the optimization of a proprietary CHO basal medium yielded valuable insight regarding the nutrient levels needed to maintain productivity. While the focus here is on the extracellular milieu of CHO cell cultures, this methodology is generally applicable to quantitating intracellular concentrations and can be extended to other mammalian cell lines, as well as platforms such as yeasts, fungi, and Escherichia
引用
收藏
页码:9531 / 9533
页数:3
相关论文
共 50 条
  • [31] Mammalian Cell Cultures for Biologics Manufacturing
    Kantardjieff, Anne
    Zhou, Weichang
    MAMMALIAN CELL CULTURES FOR BIOLOGICS MANUFACTURING, 2014, 139 : 1 - 9
  • [32] Regulating apoptosis in mammalian cell cultures
    Nilou Arden
    M. J. Betenbaugh
    Cytotechnology, 2006, 50 : 77 - 92
  • [33] PROTEIN TURNOVER IN MAMMALIAN CELL CULTURES
    EAGLE, H
    PIEZ, KA
    FLEISCHMAN, R
    OYAMA, VI
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1959, 234 (03) : 592 - 597
  • [34] Regulating apoptosis in mammalian cell cultures
    Arden, Nilou
    Betenbaugh, M. J.
    CYTOTECHNOLOGY, 2006, 50 (1-3) : 77 - 92
  • [35] Defining viability in mammalian cell cultures
    Susan M. Browne
    Mohamed Al-Rubeai
    Biotechnology Letters, 2011, 33 : 1745 - 1749
  • [36] SEROLOGICAL ADHESION IN MAMMALIAN CELL CULTURES
    KANO, K
    MILGROM, F
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1965, 28 (05): : 231 - &
  • [37] INCORPORATION OF HEPARIN IN MAMMALIAN CELL CULTURES
    DEOCA, HM
    DIETRICH, CP
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1969, 131 (02): : 662 - &
  • [38] Monitoring of Live Cell Cultures during Apoptosis by Phase Imaging and Raman Spectroscopy
    Sharikova, Anna
    Saide, George
    Sfakis, Lauren
    Park, Jun Yong
    Desta, Habben
    Maloney, Maxwell C.
    Castracane, James
    Mahajan, Supriya D.
    Khmaladze, Alexander
    QUANTITATIVE PHASE IMAGING III, 2017, 10074
  • [39] Whole-cell Escherichia coli lactate biosensor for monitoring mammalian cell cultures during biopharmaceutical production
    Goers, Lisa
    Ainsworth, Catherine
    Goey, Cher Hui
    Kontoravdi, Cleo
    Freemont, Paul S.
    Polizzi, Karen M.
    BIOTECHNOLOGY AND BIOENGINEERING, 2017, 114 (06) : 1290 - 1300
  • [40] Online flow cytometry for monitoring apoptosis in mammalian cell cultures as an application for process analytical technology
    Darrin Kuystermans
    Mohd Avesh
    Mohamed Al-Rubeai
    Cytotechnology, 2016, 68 : 399 - 408